Results 81 to 90 of about 65,450 (271)

Middle segment pancreatectomy for a solid serous cystadenoma diagnosed by MRCP and review of the literature: A case report

open access: yesMolecular and clinical oncology, 2018
Solid serous cystadenoma of the pancreas is the rarest subtype of serous cystadenoma. Cystic structures are difficult to recognize by imaging studies.
Yuichiro Okumura   +17 more
semanticscholar   +1 more source

Resected serous cystic neoplasms of the pancreas: Locally aggressive behavior as a predictor of malignant disease? A review of 158 patients with recommendations for treatment. [PDF]

open access: yes, 2007
Background: Serous cystic neoplasms of the pancreas are regarded as a benign entity with rare malignant potential. Surgical resection is generally considered curative.
Cameron, John L.   +8 more
core   +1 more source

History of gradient advances in SRF [PDF]

open access: yesarXiv, 2020
Radio frequency (RF) superconductivity has become a key technology for many modern particle accelerators. One of its most salient features of this technology is the ability of superconducting RF cavities to deliver high accelerating gradients in continuous-wave and long-pulse modes of operation. However, reaching the current state of the technology was
arxiv  

Comparison between imprint cytology and frozen sections in intraoperative consultation of ovarian tumours [PDF]

open access: yes, 2020
Background: The ovaries frequently are the site for various primary tumors. Correct intraoperative diagnosis is crucial. The application of imprint cytology is very useful where frozen section facility is not available.
Chacko, Kuruvilla P.   +2 more
core   +2 more sources

Serous cystadenoma of pancreas: A clinicopathologic experience of 23 cases from a major tertiary care center

open access: yesRare Tumors, 2018
Background: Serous cystadenomas of pancreas are rare benign epithelial neoplasms, which predominantly occur in the pancreatic body and tail of elderly females. Majority of these tumors have microcystic appearance. Macrocystic and solid variants have also
M. Tariq   +3 more
semanticscholar   +1 more source

A CASE OF SEROUS CYSTADENOMA OF THE PANCREAS

open access: yesNihon Rinsho Geka Gakkai Zasshi (Journal of Japan Surgical Association), 2000
We experienced a case of serous cystadenoma of the pancreas which was diagnosed after operation with a preoperative diagnosis of non-functioning islet cell tumor of the pancreas. A 68-year-old woman was pointed out having a tumor about 1cm in size at the pancreatic body on an abdominal ultrasonography when she had a physical examination.
Minoru Moriwaki   +5 more
openaire   +3 more sources

Identification of Sphingosine Kinase 1 as a Novel Protein Regulated by High Molecular Weight Hyaluronan in Ovarian Cancer

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 9, May 2025.
ABSTRACT The effects of hyaluronan (HA) in cancer are widely studied; however, the role of different molecular weight HA is poorly understood. Identifying novel proteins regulated by different molecular weight HA may highlight novel therapeutic targets. Proteomics analysis was performed to identify novel proteins regulated by different molecular weight
Zoe K. Price   +12 more
wiley   +1 more source

Ovarian Fibroma with Serous Cystadenoma—An Unusual Combination: A Case Report

open access: yesCase Reports in Obstetrics and Gynecology, 2012
Surface epithelial tumors account for more than 90% of ovarian tumors, of which serous tumors comprise 46%. Sex-cord stromal tumors constitute 8% of ovarian tumors, fibroma being the commonest, comprising 70% in this category.
P. S. Jayalakshmy   +3 more
doaj   +1 more source

An integrated proteomic and glycoproteomic approach uncovers differences in glycosylation occupancy from benign and malignant epithelial ovarian tumors

open access: yesClinical Proteomics, 2017
Background Epithelial ovarian carcinomas encompass a heterogeneous group of diseases with a poor 5-year survival rate. Serous carcinoma is the most common type. Most FDA-approved serum tumor markers are glycoproteins.
Qing Kay Li   +6 more
doaj   +1 more source

Atypical proliferating mucinous tumors of gigantic dimensions [PDF]

open access: yes, 2008
Background. Ovarian tumors of low malignant potential (LMP) are also known as atypically proliferating tumors. Ovarian tumors of LPM account for approximately 15% of all epithelial ovarian cancers. Mean age of occurrence is 40 years and they are 15-20 cm
Atanacković Jasmina   +7 more
core   +1 more source

Home - About - Disclaimer - Privacy